mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0002 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0004 |